| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (groß) | News + Adhoc | Bilanz/GuV | Termine | Zertifikate | Depot |
| Times + Sales | Chart-Analyse | Analysen | Dividende/HV | Profil | Optionsscheine | Watchlist |
| Börsenplätze | Chartvergleich | Kursziele | Vergleich | Insidertrades | Knock-outs | myHome |
| Orderbuch | Realtime Stuttgart | RSS Feed | Analyse | im Forum | Fonds | Senden |
| Historisch | Realtime Push | myNews neu | IR-Daten | Anleihen | handeln | |
| Analyst | Buy | Hold | Sell | Kursziel* | Abstand | Datum |
|---|---|---|---|---|---|---|
| RBC Capital Markets | - | - | 21.05.12 | |||
| Banc of America Securities-Merrill Lynch | 80,00$ | +15,71% | 30.04.12 | |||
| Barclays Capital | 86,00$ | +24,39% | 03.04.12 | |||
| Stifel, Nicolaus & Co., Inc. | 87,00$ | +25,83% | 16.03.12 | |||
| Der Aktionär | 70,00€ | - | 09.02.12 | |||
| UBS AG | 88,00$ | +27,28% | 27.01.12 | |||
| Sanford C. Bernstein and Co., Inc. | 90,00$ | +30,17% | 04.01.12 | |||
| Jefferies & Company Inc. | 72,00$ | +4,14% | 15.12.11 | |||
| Citigroup Corp. | 76,00$ | +9,92% | 07.12.11 | |||
| Leerink Swann LLC | - | - | 02.12.11 |
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 3 | 1 | 1 | 60,00 $ | -2,96% |
| AstraZeneca plc | 2 | 4 | 5 | 28,19 £ | +8,51% |
| Bayer | 15 | 12 | 0 | 61,22 € | +19,78% |
| Bristol-Myers Squibb Co. | 2 | 1 | 0 | 35,33 $ | +5,46% |
| Celgene Corp. | 9 | 1 | 0 | 82,71 $ | +19,63% |
| GlaxoSmithKline plc (GSK) | 5 | 8 | 1 | 15,31 £ | +8,66% |
| Johnson & Johnson | 5 | 4 | 0 | 71,80 $ | +15,58% |
| Merck Co. | 2 | 3 | 0 | 38,50 $ | +2,94% |
| Novartis AG | 10 | 8 | 1 | 56,60 | +11,97% |
| Pfizer Inc. | 7 | 4 | 1 | 23,75 $ | +7,51% |